Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian Cancer

Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian Cancer

Long non-coding RNAs (lncRNAs) are emerging as regulators in cancer development and progression, and aberrant lncRNA profiles have been reported in several cancers. Here, we evaluated the potential of using the maternally expressed gene 3 (MEG3) tissue level as a prognostic marker in high-grade sero...

Full description

Bibliographic Details
Main Authors: Marianna Buttarelli, Marta De Donato, Giuseppina Raspaglio, Gabriele Babini, Alessandra Ciucci, Enrica Martinelli, Pina Baccaro, Tina Pasciuto, Anna Fagotti, Giovanni Scambia, Daniela Gallo
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Cancers
Subjects:
MEG3
lncRNAs
progression-free survival
overall survival
cancer biomarkers
ovary
Online Access:https://www.mdpi.com/2072-6694/12/4/966

Internet

https://www.mdpi.com/2072-6694/12/4/966

Similar Items